TY  - JOUR

T1  - CHAMPAIN study: Initial results from a phase II study of efficacy, safety and tolerability of modified-release hydrocortisones: Chronocort® (Efmody®) versus Plenadren®, in primary adrenal insufficiency

JO  - Endocrine Abstracts

UR  - http://dx.doi.org/10.1530/endoabs.99.rc3.4

PY  - 2024/05/06

AU  - Prete A

AU  - Theiler-Schwetz V

AU  - Arlt W

AU  - Chifu I-O

AU  - Harbeck B

AU  - Napier C

AU  - Newell-Price JDC

AU  - Rees A

AU  - Reisch N

AU  - Stalla GK

AU  - Aslam N et al

ED  - 

DO  - DOI: 10.1530/endoabs.99.rc3.4

PB  - Bioscientifica

Y2  - 2024/12/22

ER  -